Search Results

• • 1 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer

  Authors:Maria del Mar Noblejas-Lopez, Cristina Nieto-Jimenez, Miguel Burgos, Monica Gomez-Juarez, Juan Carlos Montero, Azucena Esparis-Ogando, et al.From:Journal of Experimental & Clinical Cancer Research (Vol. 38, Issue 1) Peer-Reviewed

  Aug. 30, 20194,225 words Report 1400LBackground Triple negative breast cancer (TNBC) is an incurable disease where novel therapeutic strategies are needed. Proteolysis targeting chimeric (PROTAC) are novel compounds that promote protein degradation by...